中国糖尿病防治指南

Size: px

Start display at page:

Download "中国糖尿病防治指南"

菘解蚁尤
7 years ago
Views:

2 ~2000 << >><<>> <<>> mgdl(7.0mmoll)110mg/dl(6.1mmol/l)126mg/dl(7.0mmol/l <<>> <<>> 1

5 2

7 3

10 4

12 5

13 6

15 7

17 8 2

18 9

20 10

22 10-1

23 * 10-2 * HbA1c LDL-C HDL-C

24 46 1 HbA1c 1 / * 11

25 mmol/l > >10.0 HbA1c% < >7.5 mmhg <130/80 >130/80 140/90 <140/90 BMIkg/m 2 <25 <27 27 <24 <26 26 TCmmol/L < HDL-Cmmol/L > <0.9 TGmmol/L < >2.2 LDL-Cmmol/L* < >3.3 *

26 4 20%30% 1/3 100mg/dl2 6mmol/L 10%<300 mg/d 100mg/dl26mmol/L<200 mg/d 5 55%65% 6 15% g/kg 0.8g/kg g/d mg/d >15mmol/L >35 2 >10 1 >15

27 %* < > *= mmol/L(>360mg/dl) 2 / 10%15%

28 2 3 HbA1C A1C HbA1C HbA1C HbA1C DCCT UKPDS HbA1C HbA1C HbA1C 2 HbA1C 3 1 HbA1C mg/dl mmol/L(300mg/dl)

29 / () /

30 2 UKPDS %50% U/kg U/kg pm 1 RI IA +NPH RI IA RI IA NPH 2 RI IA +NPH RI IA +NPH 3 * RI IA + RI IA RI IA Glargine PZI RI=IA =NPH=PZI= *RI IA Glargine PZI

31 <130/80mmHgACEI mg/dl mg/dl mg/dl mg/dlhba1c >105 mg/dl 2 >140 mg/dl

32 [3mg/dl(2.65mmol/L),<50ml/min] / %40%

33 1 C >60 > IGT 65 10%20%

34 13

37 14

42 14-5

44 2

45 PTCA CT,MRI L- rt-pa

46 % 3: 4 99% 1 60% NPDR NPDR NPDR NPDR PDR 1

47 NPDR PDR % 1 500m 500m 2 50% 4 5 NPDR PDR NPDR PDR 6 Mongensen

48 GFRGFR 2 UAER<20g/min <30mg/d GFR GBM 3 UAER 20200g/min 30300mg/d GFR GBM 4 >3.5g/d GFR UAER 20200g/min 30300mg/d GBM Kimmelstiel-Wilson 1 <6.1mmol/L(110mg/dl) <8.0mmol/L(144mg/dl)<6.5% 2ACEI II ARB ACEI ARB %50% 4>265mol/L(3mg/dl) 3

49 <1.0g/d <130/80mmHg>1.0g/d <125/75mmHg 4 TC<4.5mmol/L,LDL-C<2.6mmol/L,HDL-C>1.1mmol/L,TG<1.5mmol/L. TC LDL-C kD kD ml/d 3g/d 2 1 ACEI ARB 0.6g/kg kJ/kg(30 35kcal/kg) 2 3 D3 4 : >530 mol/l(6mg/dl),<1520ml/min % 2 3

50 4 5 2% 10 60%90% 30%40% >90 / QT 2 3 4

51 5 6: 1 1 EC 2 B1B12 B12 3 E IU/d 2 1/ mg/d / %22% % 5

52 %0.05% mmol/L 2 8.8mmol/L

53 2 Charcot 0.1%0.4% /3 73% % 2 () : 31.5%27.4%(21.8%)(10.2%) (9.1%) X. Charcot X 3,,, 5%10% 1% %, 7.3% 80%

54 Wagner Wagner cellulitis g Charcot X Biothesiometer TcPO

55 % 3 4 NIH 1993 impotence (erectile dysfunction,ed)

56 ED ED ED ED ED 1 100% ED 2 ED 3 ED 4 ED 5 ED ED II EF EDII EF-5 ED 98% 88%II EF-5

57 1 ED 2 ED 3 i. sidenafil-5pde5 ii. trazodoneapomorphine 4 E1PGE1 PGE1 5 6 ED 35 1%3% % 88% 4.4%18.2%, 19.3%24.1%,,, 66.5% 99.2% X X 75% 12 CT

58 B6 X 15 30%50% / / /

59 /23/ self-rating depression scale,sds 2 (self-rating anxiety scale,sas) /5

60 / TGF- 1 ICAM-1 1

61 1 2 MRFIT nicotine replacement therapy NRT 1 40%60% 4mg 2mg NHANESI

62 <10% MODY 0.5 3

卫生部脑卒中筛查与防治工程委员会主任陈竺卫生部部长副主任马晓伟卫生部副部长尹力卫生部副部长王陇德中国工程院院士中华预防医学会会长委员王羽卫生部医政司司

卫生部脑卒中筛查与防治工程委员会主任陈竺卫生部部长副主任马晓伟卫生部副部长尹力卫生部副部长王陇德中国工程院院士中华预防医学会会长委员王羽卫生部医政司司脑卒中百问 STROKE 100 Questions 脑卒中百问编委会主编王陇德中国工程院院士中华预防医学会会长副主编贾建平中华医学会神经病学分会主任委员凌锋中国医师协会神经外科分会会长霍勇中国医师协会心血管内科分会会长纪立